iHuman (IH) Financial Statements

94 Followers

iHuman Financial Overview

iHuman's market cap is currently $84.07M. The company's EPS TTM is $10.58; its P/E ratio is 1.58; and it has a dividend yield of 3.93%. iHuman is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Mar 23	Dec 21
Income Statement
Total Revenue	¥ 807.02M	¥ 922.20M	¥ 1.02B	¥ 985.52M	¥ 944.72M
Gross Profit	¥ 547.61M	¥ 640.15M	¥ 721.27M	¥ 691.17M	¥ 660.62M
Operating Income	¥ 66.76M	¥ 71.91M	¥ 159.89M	¥ 111.58M	¥ -54.25M
EBITDA	¥ 74.50M	¥ 85.57M	¥ 171.58M	¥ 122.41M	¥ -47.83M
Net Income	¥ 95.40M	¥ 98.59M	¥ 180.91M	¥ 109.82M	¥ -37.05M
Balance Sheet
Cash & Short-Term Investments	¥ 1.15B	¥ 1.17B	¥ 1.21B	¥ 1.05B	¥ 855.36M
Total Assets	¥ 1.37B	¥ 1.42B	¥ 1.45B	¥ 1.33B	¥ 1.10B
Total Debt	¥ 11.38M	¥ 14.91M	¥ 3.86M	¥ 9.02M	¥ 34.25M
Net Debt	¥ -1.14B	¥ -1.11B	¥ -1.21B	¥ -1.04B	¥ -821.12M
Total Liabilities	¥ 373.42M	¥ 458.80M	¥ 492.69M	¥ 563.95M	¥ 492.51M
Stockholders' Equity	¥ 995.80M	¥ 960.85M	¥ 957.80M	¥ 769.45M	¥ 608.37M
Cash Flow
Free Cash Flow	¥ 45.15M	¥ 51.10M	¥ 165.61M	¥ 1.25B	¥ 5.93M
Operating Cash Flow	¥ 49.92M	¥ 58.55M	¥ 172.12M	¥ 1.29B	¥ 38.21M
Investing Cash Flow	¥ 39.45M	¥ -52.76M	¥ -6.51M	¥ -225.03M	¥ -31.95M
Financing Cash Flow	¥ -54.56M	¥ -102.28M	¥ -9.45M	¥ -47.66M	¥ 410.00K

Currency in CNY

iHuman Earnings and Revenue History

Income Statement >

iHuman Debt to Assets

Balance Sheet >

iHuman Cash Flow

Cash Flow >

iHuman Forecast EPS vs Actual EPS

Earnings >